Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06644261 · ClinicalTrials.gov registry record · Phase 4
Transvaginal Versus Fluoroscopy-guided Trans Gluteal Pudendal Nerve Block for Pudendal Neuralgia
A Phase 4 study of Chronic Pelvic Pain Syndrome and Pudendal Neuralgia, sponsored by University of Louisville.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT06644261 is a Phase 4 study of Chronic Pelvic Pain Syndrome and Pudendal Neuralgia that is actively recruiting participants, run by University of Louisville. The registered enrollment target is 40 participants, below the 193-participant average among 11 other Chronic Pelvic Pain Syndrome trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06644261, a Phase 4 study of Chronic Pelvic Pain Syndrome and Pudendal Neuralgia, is actively recruiting participants, sponsored by University of Louisville.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Chronic pain affecting the pelvic and urogenital area is a major clinical problem and can have a profound impact on quality of life and health care costs. Pelvic pain arising from entrapment or neuropathy of the pudendal nerve is known as pudendal neuralgia, which results in chronic perineal pain. This pain syndrome is difficult to diagnose and patients with pudendal neuralgia may present to providers with refractory chronic pelvic pain. Pudendal nerve infiltration or pudendal nerve block (PNB) serves as a diagnostic tool and treatment modality for patients with this condition. To date, there are no published randomized controlled trials comparing imaging-guided PNB to transvaginal finger-guided PNB. While one can assume that image-guided nerve blocks will provide better accuracy for injection and potentially better efficacy in pain relief as a result, no published data exists comparing the outcomes and efficacy between modalities. The purpose of this prospective, non-inferiority, randomized controlled trial is to compare the efficacy of pain relief from bilateral transvaginal finger-guided pudendal nerve block versus bilateral fluoroscopy-guided trans gluteal pudendal nerve block for patients with pudendal neuralgia.
Conditions Studied
Interventions
- DRUG Bupivacaine injection
Study Locations (1)
Kentucky
- University of Louisville Division of Urogynecology and Reconstructive Pelvic Surgery - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-06-27 |
| Est. Completion | 2029-07-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06644261
The ClinicalTrials.gov registry entry for NCT06644261 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 193-participant average among 11 other Chronic Pelvic Pain Syndrome trials with a reported enrollment target (79% lower). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Pelvic Pain Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Bupivacaine injection is the first listed.
NCT06644261 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT06644261 about?
NCT06644261 is a clinical study titled "Transvaginal Versus Fluoroscopy-guided Trans Gluteal Pudendal Nerve Block for Pudendal Neuralgia". Chronic pain affecting the pelvic and urogenital area is a major clinical problem and can have a profound impact on quality of life and health care costs. Pelvic pain arising from entrapment or neuropathy of the pudendal nerve is known as pudendal neuralgia, which results in chronic perineal pain. T...
What is the current status of trial NCT06644261?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2024-06-27. Estimated completion is 2029-07-01.
What conditions does trial NCT06644261 study?
This clinical trial studies the following conditions: Chronic Pelvic Pain Syndrome, Pudendal Neuralgia.
What interventions are being tested in trial NCT06644261?
The interventions under investigation include: Bupivacaine injection (DRUG).
Who is sponsoring clinical trial NCT06644261?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06644261 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pelvic Pain Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Evaluation of Effectiveness and Safety of Closed-Loop Spinal Cord Stimulation in Treating Patients With Chronic Pelvic Pain
RECRUITING · NA
-
Musculoskeletal and Pelvic Floor Health in Female Chronic Overlapping Pelvic Pain Conditions
RECRUITING
-
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain
RECRUITING · NA
-
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
RECRUITING
-
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
RECRUITING · NA
-
Vaginal Baclofen Suppositories in Chronic Pelvic Pain
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.